LONDON, U.K.–Technavio has published a new report on the pharmaceutical logistics market in North America, which is expected to grow at a CAGR of more than 8% from 2015-2019.
Technavio’s report analyses the solutions and products offered by market vendors and presents a comprehensive breakdown in terms of market segmentation for different products, including generic drugs, branded drugs, and other drugs.
Additionally, analysts have segmented market projections by key geography, focusing on the U.S., Canada, and Mexico, said the release.
“It has been established that pharmaceutical logistics vendors in North America have found new opportunities in the biological drugs market, which can increase their revenue and market share. The growth of the biological drug market is due to increased use of biological drugs for the treatment of many chronic diseases,” says Faisal Ghaus, Vice President of Technavio.
Industry analysis includes a look at key vendors, market growth drivers, market challenges (stringent regulations and complex supply chains), and market trends, (including a shift toward biological drugs, and the emergence of big data analytics in SCM.)